Clinical research is going digital.

We'll make sure it's safe and sound.

Triall is laying the groundwork for tomorrow’s digital playing field in medical research and clinical trials. We are developing an infrastructure of blockchain-integrated microservices, facilitating safe and efficient data exchanges between researchers and their many isolated software systems.

Our mission is to accelerate the introduction of safe and affordable vaccines and therapeutics into society by streamlining modern clinical trial operations.

Deep Industry Experience

Combined, our team has managed 100+ clinical trials across 30+ countries, and successfully grown companies both in the Life Sciences and Software/Blockchain-as-a-Service industries.

Thought Leaders

Our team has published 250+ peer-reviewed papers on innovation in medical research, featured in top-tier scientific journals such as Nature and Science Magazine.

Global Partner & Customer Network

Years of industry operations have gained us a strong value network of partners and potential customers that stretches the globe.

Double-Digit Growth

Our target market is characterized by rapid digitalization, decentralization, and double-digit growth (CAGR of 13.8%). High upside is projected for those that can underpin this emerging digital ecosystem. Our solutions are specifically designed to do so.

Working Product

Our first product Verial eTMF is in production and currently being onboarded by 6 commercial clinical trial projects across 3 countries, involving an approximate total of 2500 participants. More projects are lined up.

Market Validation

Leading stakeholders in our customer domain have expressed interest in our first products, which directly respond to actual customer pain points.

You may have heard about us

Blockchain-integrated solutions, developed with and for medical research professionals

Blockchain-integrated solutions, developed with
and for medical research professionals

Key Industry Advisors

As a first demonstration of our blockchain-integrated infrastructure, we are developing a series of clinical trial software applications. We have been working closely with the medical research industry to ensure that each of these ‘eClinical solutions’ targets specific industry pain points.

The underlying product concepts have been validated with a Seal of Excellence by industry experts of the European Commission’s Horizon2020 program for top research and innovation.

Our modular but complementary eClinical solutions are all designed to greatly improve data integrity, auditability, and task efficiency in modern-day medical research processes. These functionalities answer to growing calls for security and traceability by industry regulators across the globe.

Core solutions

  • Verial eTMFClinical document management solution with blockchain proofs of data integrity and authenticity
  • Triall CTMSLightweight trial management dashboard with blockchain API-driven data integration
  • Atena PRMVendor selection and management platform with blockchain proofs of fair tender and bidding processes

Management team

  • Hadil Es-Sbai, MSc

    President | CEO

    Empathetic and tireless leader with extensive clinical development expertise. Innovator and team builder. Founder of multiple successful service companies in the Life Sciences.

  • Niels Klomp, MSc

    CTO

    Experienced blockchain and SaaS developer. Serial tech entrepreneur with 15+ years’ experience in various CTO roles. Guide of the Factom Blockchain.

  • Dr. Linda van de Burgwal

    CFO

    Academic entrepreneur, project manager and consultant. Co-founder of two successful Life Sciences management consultancies. Holds a cum laude PhD in science commercialization.

  • Rob Posthumus, LL.M.

    General Counsel

    Corporate lawyer and deal-maker with extensive experience as legal counsel in the pharma & health care industries. Headed the legal department of Erasmus University Medical Center.

  • Raymond van der Waal, MSc

    Head of Marketing

    Researcher, consultant, and copywriter with a background in Biomedical Sciences and Entrepreneurship. Passion for making complex technologies understandable for a broader audience.

  • Dr. Joost Flach

    Head of Clinical Affairs

    Clinical researcher, project manager and medical writer, operating at the interface between industry and academia. Early crypto enthusiast, dedicated to realizing end-user functionalities.

  • Mark van der Waal, MSc

    Head of Design

    PhD candidate and consultant in medical innovation management with degrees in Health Technology Assessment and Management. Passionate designer with 12 years’ experience in UI / UX projects.

  • Sina DjaliHead of Integrated Data Analytics
    Janssen Pharmaceuticals (J&J)
  • Danielle BradburyVP Quality Assurance
    Galera Therapeutics
  • Prof. Niels Chavannes, MD, PhDHead of Research, Public Health & Primary Care Leiden University Medical Center
  • Cari Jacobs BlomDirector Quality & Compliance
    CR2O
  • Prof. Sjaak Bloem, PhDAssociate Director Behavioral Science
    Janssen Pharmaceuticals (J&J)
  • Allan BukuyaCOO
    TrialDocs International
  • Nick van den BulkHead Clinical Operations
    CR2O
  • Prof. Eric Claassen, PhDSequential Biotech Entrepreneur
    & Angel Investor Multiple ventures

Key Industry Advisors

  • Sina DjaliHead of Integrated Data Analytics
    Janssen Pharmaceuticals (J&J)
  • Danielle BradburyVP Quality Assurance
    Galera Therapeutics
  • Prof. Niels Chavannes, MD, PhDHead of Research, Public Health & Primary Care Leiden University Medical Center
  • Cari Jacobs BlomDirector Quality & Compliance
    CR2O
  • Prof. Sjaak Bloem, PhDAssociate Director Behavioral Science
    Janssen Pharmaceuticals (J&J)
  • Allan BukuyaCOO
    TrialDocs International
  • Nick van den BulkHead Clinical Operations
    CR2O
  • Prof. Eric Claassen, PhDSequential Biotech Entrepreneur
    & Angel Investor Multiple ventures

A glimpse into Triall

Registration for our
limited token pre-sale has begun

Triall welcomes both retail and institutional investors to join the whitelist.

If you'd like to be part of our Private Pre-sale cohort, please help us understand what makes your commitment special. What value can you bring to the growth of Triall?



Desired ticket size:            
If you want to be part of our pre-sale investors cohort, please help us understand what makes your commitment special (Max. 255 characters):



Resources

Whitepaper

Pitch Deck

  • Version2.2
  • ReleasedApril 2021

Contact information

Triall Foundation Office

Bisonspoor 3002 – C701 (Copenhagen Tower), 3605 LT Maarssen, The Netherlands

E-MAIL (GENERAL)

contact@triall.io

Press & Media

press@triall.io

Chamber of Commerce (Stichting Triall Foundation)

71656227

GDPR